9JGO
Structure of Pd ions bound to human heavy chain ferritin nanocage.
Summary for 9JGO
| Entry DOI | 10.2210/pdb9jgo/pdb |
| Descriptor | Ferritin heavy chain, N-terminally processed, MAGNESIUM ION, PALLADIUM ION, ... (4 entities in total) |
| Functional Keywords | granzyme b; nanovesicles; ferritin; palladium, apoptosis |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 21410.21 |
| Authors | Liu, Y.J.,Zhao, M.,Chen, C.,Hu, X.Y.,Kang, H.L.,Liu, Q.Q.,Huang, X.L. (deposition date: 2024-09-08, release date: 2025-09-10, Last modification date: 2026-03-25) |
| Primary citation | Hu, X.,Liu, Q.,Kang, H.,Zhao, M.,Zhou, Z.,Li, Y.,Peng, W.,Qi, T.,Liu, R.,Jiao, L.,Zhuang, J.,Liu, Y.,Mann, S.,Huang, X. Granzyme B-mimetic nanozyme for nanovesicle targeted anticancer applications. Nat Commun, 17:-, 2026 Cited by PubMed Abstract: Cytotoxic T lymphocytes play a crucial role in anti-tumour immunity, with granzyme B (GrB) being a decisive factor in this process. Developing a GrB-based delivery system to mimic T cell-based immunotherapy holds promise but remains challenging. Here, we present an artificial metalloenzyme (nanozyme) with GrB-like protease activity capable of inducing caspase-dependent cell apoptosis. The nanozyme is based on the site-specific binding of Pd(II) ions to recombinant human heavy chain apo-ferritin nanocages to generate a binuclear catalytic centre consisting of two Pd atoms with bridging cysteine ligands, monodentate methionine and histidine residues, and two water molecules. We show that encapsulation of the Pd-ferritin complex within membrane-fused lipid nanoparticles comprising surface-displayed single-chain antibodies affords GrB-mimicking nanozyme-based nanovesicles capable of receptor-mediated delivery of the nanozyme into the cytoplasm of tumour cells and induction of caspase-dependent apoptosis. This study provides valuable insights into the construction of nano-delivery systems with artificial GrB activity and presents a promising therapeutic option for solid tumours. PubMed: 41587995DOI: 10.1038/s41467-026-68773-x PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.851 Å) |
Structure validation
Download full validation report






